Follow
Eva Culakova
Eva Culakova
Research Assistant Professor, University of Rochester Medical Center
Verified email at urmc.rochester.edu
Title
Cited by
Cited by
Year
Development and validation of a predictive model for chemotherapy-associated thrombosis
AA Khorana, NM Kuderer, E Culakova, GH Lyman, CW Francis
Blood, The Journal of the American Society of Hematology 111 (10), 4902-4907, 2008
23612008
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
AA Khorana, CW Francis, E Culakova, NM Kuderer, GH Lyman
Journal of Thrombosis and Haemostasis 5 (3), 632-634, 2007
18972007
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
AA Khorana, CW Francis, E Culakova, NM Kuderer, GH Lyman
Cancer: Interdisciplinary International Journal of the American Cancer …, 2007
10542007
Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study
AA Khorana, CW Francis, E Culakova, GH Lyman
Cancer: Interdisciplinary International Journal of the American Cancer …, 2005
7162005
Thromboembolism in hospitalized neutropenic cancer patients
AA Khorana, CW Francis, E Culakova, RI Fisher, NM Kuderer, GH Lyman
Journal of Clinical Oncology 24 (3), 484-490, 2006
6242006
Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer
AA Khorana, CW Francis, N Blumberg, E Culakova, MA Refaai, ...
Archives of internal medicine 168 (21), 2377-2381, 2008
4762008
Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study
SG Mohile, MR Mohamed, H Xu, E Culakova, KP Loh, A Magnuson, ...
The Lancet 398 (10314), 1894-1904, 2021
3192021
Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial
IR Kleckner, C Kamen, JS Gewandter, NA Mohile, CE Heckler, ...
Supportive Care in Cancer 26 (4), 1019-1028, 2018
3082018
Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy
GH Lyman, NM Kuderer, J Crawford, DA Wolff, E Culakova, ...
Cancer 117 (9), 1917-1927, 2011
2872011
Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice
J Crawford, DC Dale, NM Kuderer, E Culakova, MS Poniewierski, D Wolff, ...
Journal of the National Comprehensive Cancer Network 6 (2), 109-118, 2008
2872008
Communication with older patients with cancer using geriatric assessment: a cluster-randomized clinical trial from the National Cancer Institute Community Oncology Research Program
SG Mohile, RM Epstein, A Hurria, CE Heckler, B Canin, E Culakova, ...
JAMA oncology 6 (2), 196-204, 2020
2232020
The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials
GH Lyman, DC Dale, E Culakova, MS Poniewierski, DA Wolff, ...
Annals of oncology 24 (10), 2475-2484, 2013
2192013
Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer
GH Lyman, E Culakova, MS Poniewierski, NM Kuderer
Thrombosis research 164, S112-S118, 2018
1682018
Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens
JJ Griggs, E Culakova, MES Sorbero, MS Poniewierski, DA Wolff, ...
Journal of clinical oncology 25 (18), 2522-2527, 2007
1662007
Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy
M Shayne, J Crawford, DC Dale, E Culakova, GH Lyman
Breast cancer research and treatment 100 (3), 255-262, 2006
1602006
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy
GC Connolly, AA Khorana, NM Kuderer, E Culakova, CW Francis, ...
Thrombosis research 126 (2), 113-118, 2010
1592010
Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose
LS Constine, N Tarbell, MM Hudson, C Schwartz, SG Fisher, AG Muhs, ...
International Journal of Radiation Oncology* Biology* Physics 72 (1), 24-33, 2008
1542008
Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy
M Shayne, E Culakova, MS Poniewierski, D Wolff, DC Dale, J Crawford, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2007
1432007
Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy
JJ Griggs, E Culakova, MES Sorbero, M Van Ryn, MS Poniewierski, ...
Journal of clinical oncology 25 (3), 277-284, 2007
1422007
Patterns of chemotherapy‐associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study
E Culakova, R Thota, MS Poniewierski, NM Kuderer, AF Wogu, DC Dale, ...
Cancer medicine 3 (2), 434-444, 2014
1212014
The system can't perform the operation now. Try again later.
Articles 1–20